BAMCO INC /NY/ - MAXCYTE INC ownership

MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 104 filers reported holding MAXCYTE INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.

Quarter-by-quarter ownership
BAMCO INC /NY/ ownership history of MAXCYTE INC
ValueSharesWeighting
Q1 2023$9,840,125
-17.4%
1,987,904
-8.9%
0.03%
-25.0%
Q4 2022$11,919,082
-19.1%
2,182,982
-3.7%
0.04%
-16.7%
Q3 2022$14,742,000
+30.3%
2,267,949
-5.2%
0.05%
+33.3%
Q2 2022$11,310,000
-64.8%
2,391,158
-48.0%
0.04%
-54.4%
Q1 2022$32,145,000
-37.7%
4,598,669
-9.2%
0.08%
-27.5%
Q4 2021$51,614,000
+173.8%
5,065,171
+228.1%
0.11%
+153.5%
Q3 2021$18,848,0001,543,6340.04%
Other shareholders
MAXCYTE INC shareholders Q4 2022
NameSharesValueWeighting ↓
NORTH RUN CAPITAL, LP 480,900$3,361,0004.94%
Casdin Capital, LLC 13,971,334$97,660,0004.38%
Vitruvian Partners LLP 4,385,670$30,656,0003.25%
RIVER GLOBAL INVESTORS LLP 2,100,000$14,849,0001.95%
APIS CAPITAL ADVISORS, LLC 180,000$1,258,0001.52%
Pier Capital, LLC 1,017,753$7,114,0000.91%
First Light Asset Management, LLC 1,321,406$9,237,0000.82%
Montanaro Asset Management Ltd 929,000$6,557,0000.81%
Nicholas Investment Partners, LP 776,963$5,431,0000.39%
Bleichroeder LP 250,000$1,764,0000.31%
View complete list of MAXCYTE INC shareholders